Kailera Therapeutics, Inc.
KLRA
$14.83
-$0.02-0.10%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.58% | -- | |||
| Total Receivables | 90.59% | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -21.87% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 9.72% | -- | |||
| Total Current Assets | 75.21% | -- | |||
|
|
|||||
| Total Current Assets | 75.21% | -- | |||
| Net Property, Plant & Equipment | -3.10% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -21.09% | -- | |||
| Total Assets | 93.90% | -- | |||
|
|
|||||
| Total Accounts Payable | 170.64% | -- | |||
| Total Accrued Expenses | 36.28% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 2.24% | -- | |||
| Total Finance Division Other Current Liabilities | -0.14% | -- | |||
| Total Other Current Liabilities | -0.14% | -- | |||
| Total Current Liabilities | 52.55% | -- | |||
|
|
|||||
| Total Current Liabilities | 52.55% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -2.93% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -32.84% | -- | |||
| Total Liabilities | 44.16% | -- | |||
|
|
|||||
| Common Stock & APIC | 10,409.47% | -- | |||
| Retained Earnings | -24.87% | -- | |||
| Treasury Stock & Other | -237.22% | -- | |||
| Total Common Equity | 358.85% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 358.85% | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 99.63% | -- | |||
|
|
|||||